The chemical hunt for the identification of drugable targets.
暂无分享,去创建一个
Manfred Auer | Volker Uhl | Thomas Weidemann | Martin Hintersteiner | Hubert Gstach | M. Auer | Martin Hintersteiner | M. Schmied | H. Gstach | Nicole-Claudia Meisner | Mario Schmied | T. Weidemann | Nicole‐Claudia Meisner | V. Uhl
[1] Robert P Bywater,et al. Recognition of privileged structures by G-protein coupled receptors. , 2004, Journal of medicinal chemistry.
[2] R. Falchetto,et al. SpeedScreen: label-free liquid chromatography-mass spectrometry-based high-throughput screening for the discovery of orphan protein ligands. , 2004, Analytical biochemistry.
[3] Peter G Schultz,et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] Matthew Bogyo,et al. A Role for the Protease Falcipain 1 in Host Cell Invasion by the Human Malaria Parasite , 2002, Science.
[5] Andy Vinter,et al. Peptides to non-peptides: leads from structureless virtual screening , 2004 .
[6] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.
[7] C. Lieber,et al. Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species , 2001, Science.
[8] P. Schultz,et al. Profiling protein function with small molecule microarrays , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Haggarty,et al. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. , 2003, Chemistry & biology.
[10] S. Schreiber. Chemical genetics resulting from a passion for synthetic organic chemistry. , 1998, Bioorganic & medicinal chemistry.
[11] Steven L. Dixon,et al. Bioactive Diversity and Screening Library Selection via Affinity Fingerprinting , 1998, J. Chem. Inf. Comput. Sci..
[12] H. Waldmann. At the crossroads of chemistry and biology. , 2003, Bioorganic & medicinal chemistry.
[13] Peter G. Schultz,et al. Synthetic small molecules that control stem cell fate , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Meldal. The one-bead two-compound assay for solid phase screening of combinatorial libraries. , 2002, Biopolymers.
[15] A. Eliseev,et al. Ketones as building blocks for dynamic combinatorial libraries: highly active neuraminidase inhibitors generated via selection pressure of the biological target. , 2003, Journal of medicinal chemistry.
[16] J. Claverie,et al. What If There Are Only 30,000 Human Genes? , 2001, Science.
[17] P. Taylor,et al. Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. , 2002, Angewandte Chemie.
[18] W. Delano,et al. In situ assembly of enzyme inhibitors using extended tethering , 2003, Nature Biotechnology.
[19] Dale L Boger,et al. Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions. , 2003, Angewandte Chemie.
[20] K. Lam,et al. Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. , 2003, Accounts of chemical research.
[21] Matthew A. Cooper,et al. Optical biosensors in drug discovery , 2002, Nature Reviews Drug Discovery.
[22] J. Drews,et al. Drug Development: The role of innovation in drug development , 1997, Nature Biotechnology.
[23] Kit S Lam,et al. Therapeutic cancer targeting peptides. , 2002, Biopolymers.
[24] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[25] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[26] B. E. Evans,et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of medicinal chemistry.
[27] Peter G Schultz,et al. Small molecules that induce cardiomyogenesis in embryonic stem cells. , 2004, Journal of the American Chemical Society.
[28] T. Groth,et al. Automated Sorting of Beads from a “One-Bead-Two-Compounds” Combinatorial Library of Metalloproteinase Inhibitors , 2003 .
[29] C. Wermuth. Selective optimization of side activities: another way for drug discovery. , 2004, Journal of medicinal chemistry.
[30] Herbert Waldmann,et al. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. , 2002, Angewandte Chemie.
[31] Julian L Griffin,et al. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. , 2003, Current opinion in chemical biology.
[32] A. Eliseev,et al. Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] Matthew A. Cooper,et al. Direct and sensitive detection of a human virus by rupture event scanning , 2001, Nature Biotechnology.
[34] D. Falb,et al. Chemical genomics: bridging the gap between the proteome and therapeutics. , 2002, Current opinion in drug discovery & development.
[35] Wolfgang Jahnke,et al. Second-site NMR screening and linker design. , 2003, Current topics in medicinal chemistry.
[36] B. Andrews,et al. Old Drugs, New Tricks Using Genetically Sensitized Yeast to Reveal Drug Targets , 2004, Cell.
[37] Chi‐Huey Wong,et al. A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry , 2003 .
[38] Young-Tae Chang,et al. Tagged library approach to chemical genomics and proteomics. , 2004, Current opinion in chemical biology.
[39] D. Vetter. Chemical microarrays, fragment diversity, label‐free imaging by plasmon resonance—a chemical genomics approach , 2002, Journal of cellular biochemistry. Supplement.
[40] Gang Liu,et al. Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors. , 2003, Bioorganic & medicinal chemistry letters.
[41] T. Mitchison,et al. Phenotypic screening of small molecule libraries by high throughput cell imaging. , 2003, Combinatorial chemistry & high throughput screening.
[42] I. Wilson,et al. Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism , 2003, Nature Reviews Drug Discovery.
[43] Horst Kessler,et al. Nonpeptidic αv β3 Integrin Antagonist Libraries: On-Bead Screening and Mass Spectrometric Identification without Tagging. , 2001, Angewandte Chemie.